Combined esterified estrogens and methyltestosterone versus esterified estrogens alone in the treatment of loss of sexual interest in surgically menopausal women

Menopause

Volumn 12, Issue 4, 2005, Pages 374-384

  Warnock, Julia K ^a   Swanson, Stephen G ^b   Borel, Raymond W ^c   Zipfel, Lisa M ^c   Brennan, John J ^c  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b Women's Clinic of Lincoln   (United States)

^c Solvay Pharmaceuticals Inc   (Netherlands)

Author keywords

Esterified estrogens; Hypoactive sexual desire; Hypoactive sexual interest desire; Methyltestosterone; Sex hormone binding globulin

Indexed keywords

ESTRADIOL; ESTRATEST; ESTRONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TRIACYLGLYCEROL;

ACNE; ADULT; AGED; ARTICLE; BIOAVAILABILITY; CHANGES IN SEXUAL FUNCTIONING QUESTIONNAIRE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FLATULENCE; HEADACHE; HIRSUTISM; HUMAN; INFECTION; INSOMNIA; IRRITABILITY; MAJOR CLINICAL STUDY; MASTALGIA; MENOPAUSE; MENOPAUSE SEXUAL INTEREST QUESTIONNAIRE; MIGRAINE; NAUSEA; NERVOUSNESS; ORGASM; OVARIECTOMY; PERIPHERAL EDEMA; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SALPINGOOOPHORECTOMY; SEXUAL AROUSAL; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; SIDE EFFECT; TESTOSTERONE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; VAGINITIS; WEIGHT GAIN; WOMENS HEALTH QUESTIONNAIRE;

ADULT; ANABOLIC AGENTS; BIOLOGICAL AVAILABILITY; DOUBLE-BLIND METHOD; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; ESTROGENS, ESTERIFIED (USP); ESTRONE; FEMALE; HUMANS; LIBIDO; MENOPAUSE; METHYLTESTOSTERONE; MIDDLE AGED; QUESTIONNAIRES; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE;

EID: 23244457049     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.GME.0000153933.50860.FD     Document Type: Article

References (22)

1. National Center for Health Statistics. 1994 Health United States. Hyattsville: Public Health Service, 1995.
2. Sowers MF, Beebe JL, McConnell D, Randolph J, Jannausch M. Testosterone concentrations in women aged 25-50 years: associations with lifestyle, body composition, and ovarian status. Am J Epidemiol 2001;153:256-264.
3. Rako S. Testosterone supplemental therapy after hysterectomy with or without concomitant oophorectomy: estrogen alone is not enough. J Womens Health Gend Based Med 2000;9:917-923.
4. Shifren JL. Androgen deficiency in the oophorectomized woman. Fertil Steril 2002;77(Suppl 4):S60-S62.
5. Sherwin BB. Affective changes with estrogen and androgen replacement therapy in surgically menopausal women. J Affect Disord 1988;14:177-187.
6. Davis AR. Recent advances in female sexual dysfunction. Curr Psychiatry Rep 2000;2:211-214.
7. Clayton A, MCGarvey E, Clavet G. The Changes in Sexual Functioning Questionnaire (CSFQ): development, reliability and validity. Psychopharm Bull 1997;33:731-745.
8. Rosen R, Lobo R, Block B, Yang HM, Zipfel L. Menopausal Sexual Interest Questionnaire: a unidimensional scale for assessment of sexual interest in postmenopausal women. J Sex Marital Ther 2004;30:235-250.
9. Warnock JJ. Female hypoactive sexual desire disorder: epidemiology, diagnosis and treatment. CNS Drugs 2002;16:745-753.
10. Warnock JK, Bundren JC, Morris DW. Female hypoactive sexual desire disorder due to androgen deficiency: clinical and psychometric issues. Psychopharmacol Bull 1997;33:761-766.
11. Spitzer RL, Williams JB, Kroenke K, et al. Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study. JAMA 1994;272:1749-1756.
12. Lobo RA, Rosen RC, Yang HM, Block B, Van Der Hoop RG. Comparative effects of oral esterified estrogens with and without methyltestosterone on endocrine profiles and dimensions of sexual function in postmenopausal women with hypoactive sexual desire. Fertil Steril 2003;79:1341-1352.
13. Hunter MS. The Women's Health Questionnaire (WHQ): frequently asked questions (FAQ). Health Qual Life Outcomes 2003;1:41.
14. Barrett-Connor E, Young R, Notelovitz M, et al. A two-year, double-blind comparison of estrogen-androgen and conjugated estrogens in surgically menopausal women. Effects on bone mineral density, symptoms and lipid profiles. J Reprod Med 1999;44:1012-1020.
15. Burger HG, Hailes J, Menelaus M, Nelson J, Hudson B, Balazs N. The management of persistent menopausal symptoms with estradiol-testosterone implants: clinical, lipid and hormonal results. Maturitas 1984;6:351-358.
16. Davis SR, Burger HG. Use of androgens in postmenopausal women. Curr Opin Obstet Gynecol 1997;9:177-180.
17. Sarrel P, Dobay B, Wiita B. Estrogen and estrogen-androgen replacement in postmenopausal women dissatisfied with estrogen-only therapy. Sexual behavior and neuroendocrine responses. J Reprod Med 1998;43:847-856.
18. Sherwin BB, Gelfand MM, Brender W. Androgen enhances sexual motivation in females: a prospective, crossover study of sex steroid administration in the surgical menopause. Psychosom Med 1985;47:339-351.
19. Plymate SR, Leonard JM, Paulsen CA, Fariss BL, Karpas AE. Sex hormone-binding globulin changes with androgen replacement. J Clin Endocrinol Metab 1983;57:645-648.
20. Floter A, Nathorst-Boos J, Carlstrom K, von Schoultz B. Addition of testosterone to estrogen replacement therapy in oophorectomized women: effects on sexuality and well-being. Climacteric 2002;5:357-365.
21. Dixson A. The evolution of neuroendocrine mechanisms regulating sexual behavior in female primates. Reprod Fertil Dev 2001;13:599-607.
22. Christiansen K. Behavioral effects of androgen in men and women. J Endocrinol 2001;170:39-48.